PM Bhartiya Jan Aushadhi Kendras

1. At a Glance

• PMBJP = Pradhan Mantri Bhartiya Janaushadhi Pariyojana, a flagship scheme to make quality generic medicines available at affordable prices through dedicated retail outlets called Jan Aushadhi Kendras (JAKs) [S1][S2].
• Implemented by the Department of Pharmaceuticals, Ministry of Chemicals and Fertilizers, with Pharmaceuticals & Medical Devices Bureau of India (PMBI) as the implementing agency [S1].
• High UPSC salience: intersects health affordability, universal health coverage, fiscal savings, MSME-style entrepreneurship, and Centre–State delivery.

2. Why in the News

• PIB release (06 Feb 2026): 17,990 JAKs operational across India as on 31.12.2025, of which 1,058 are in Bihar [S1].
• Product basket expanded to 2,110 medicines + 315 surgicals/consumables/devices, including nutraceuticals like protein powders [S1].

3. Background & Evolution

• Launched in 2008 as the Jan Aushadhi Scheme by the Department of Pharmaceuticals [S2].
• Rebranded in 2016 as Pradhan Mantri Bhartiya Janaushadhi Pariyojana (PMBJP) with expanded scope [S2].
• 10,000th JAK inaugurated at AIIMS Deoghar in 2023; concurrent launch of programme to scale from 10,000 → 25,000 kendras [S3].
• ₹1,000 crore sales milestone achieved in FY 2023-24 [S2].

4. Core Static Facts

• Parent Ministry: Ministry of Chemicals and Fertilizers → Department of Pharmaceuticals [S1].
• Implementing Agency: PMBI (Pharmaceuticals & Medical Devices Bureau of India), under Dept. of Pharmaceuticals [S2].
• Portal: www.janaushadhi.gov.in [S2].
• Product basket: 2,110 medicines + 315 surgicals/devices spanning cardiovascular, anti-cancer, anti-diabetic, anti-infective, anti-allergic, GI categories [S1].
• Pricing: MRPs 50–80% lower than branded equivalents [S2].
• Quality: Procured only from WHO-GMP compliant manufacturers; batch testing at NABL-accredited labs [S2].
• Target: 25,000 JAKs by March 2027 [S2].
• Incentive to JAK owner: 10% of monthly purchases, ceiling ₹10,000/month; plus up to ₹10,000/month for maintaining stock of 200 high-demand products [S2].
• One-time special incentive of ₹2 lakh for JAKs in NE States, Himalayan areas, island territories, NITI Aayog Aspirational Districts, and for entrepreneurs from SC/ST, Divyangjan, Ex-servicemen categories [S2].

5. Multi-Dimensional Analysis

Economic / Fiscal - By June 2025: aggregate MRP-value sales of ₹7,700 crore, estimated citizen savings of ~₹38,000 crore vs branded equivalents [S2]. - Reduces out-of-pocket health expenditure (OOPE), contributing to UHC and Ayushman Bharat outcomes. - Generates micro-entrepreneurship via franchise-based JAK model [S2].

Social - Targets affordability for lower-income, rural, and chronic-disease patients (diabetes, CVD, cancer) [S1]. - Affirmative inclusion via ₹2-lakh incentive for SC/ST, Divyangjan, Ex-servicemen [S2].

Administrative / Governance - Franchise model: applications from individuals, NGOs, trusts, societies, firms, companies [S2]. - Centre-led scheme but spatial spread depends on State application density (e.g., Bihar 1,058 of 17,990) [S1].

Scientific / Quality Assurance - Mandatory WHO-GMP + NABL testing addresses common public scepticism around generics [S2].

Ethical / Public Health - Tackles asymmetry between branded vs generic pricing; furthers right to health as derived under Article 21 (judicial reading).

6. Recent Developments (last 12–18 months)

• 30 Jun 2025: 16,912 JAKs operational; 25,000 target by March 2027 reiterated [S2].
• 31 Dec 2025: count rose to 17,990 JAKs; Bihar at 1,058 [S1].
• Product basket scaled to 2,110 medicines + 315 devices as of Feb 2026 release [S1].
• Jan Aushadhi Diwas 2025 celebrated with "Bal Mitra" outreach (children-focused awareness) [S2].

7. Prelims Hooks

• PMBJP launched in 2008; renamed in 2016 [S2].
• Implementing agency: PMBI (not NPPA, not CDSCO) [S2].
• Parent ministry: Chemicals and Fertilizers (not Health & Family Welfare) [S1].
• Target: 25,000 JAKs by March 2027 [S2].
• As on 31.12.2025: 17,990 JAKs; Bihar = 1,058 [S1].
• Product basket: 2,110 medicines + 315 surgicals/devices [S1].
• Prices 50–80% below branded equivalents [S2].
• Quality benchmarks: WHO-GMP + NABL [S2].
• Monthly incentive cap: ₹10,000 (10% of purchases) [S2].
• Special one-time grant: ₹2 lakh for NE/Himalayan/island/Aspirational District JAKs and SC/ST/Divyangjan/Ex-servicemen [S2].
• 10,000th kendra inaugurated at AIIMS Deoghar [S3].
• Estimated citizen savings: ~₹38,000 crore (by mid-2025) [S2].
• Portal: janaushadhi.gov.in [S2].

8. Mains Relevance

• GS-II — Government schemes for vulnerable sections; Health; Issues relating to development and management of Social Sector / Services.
• GS-III — Inclusive growth; Pharma sector.
• Probable stems: 1. "Discuss how PMBJP advances the goal of Universal Health Coverage while reducing out-of-pocket expenditure in India." 2. "Examine the role of generic medicines and Jan Aushadhi Kendras in addressing healthcare affordability. What bottlenecks constrain scale-up to the 25,000 target?" 3. "PMBJP combines social welfare with micro-entrepreneurship. Critically analyse."

9. Related Topics to Study Next

• Ayushman Bharat – PMJAY — complementary OOPE-reduction lever.
• National Pharmaceutical Pricing Authority (NPPA) & DPCO 2013 — price control of essential drugs.
• National List of Essential Medicines (NLEM) — basket overlap with PMBJP.
• PLI Scheme for Pharmaceuticals & Bulk Drugs Parks — supply-side counterpart.
• CDSCO & Drugs and Cosmetics Act, 1940 — regulatory backbone.
• Ayushman Bharat Health Infrastructure Mission (PM-ABHIM).
• Aspirational Districts Programme — used for PMBJP incentive geography.
• WHO-GMP & NABL accreditation — quality assurance frameworks.

10. Common Errors / Trap Areas

• Wrong ministry: PMBJP sits under Chemicals & Fertilizers, NOT Health & Family Welfare.
• Implementing body is PMBI, not NPPA or CDSCO.
• Launch year is 2008; 2015–16 is the renaming/relaunch, not the original launch.
• Target is 25,000 by March 2027, not 2025 or 2030.
• JAKs sell quality-tested generics, not "branded" or "Ayurveda" drugs — distinct from AYUSH outlets.
• ₹2-lakh special incentive applies only to specified categories/geographies — not universal.

11. Sources

• [S1] PM Bhartiya Jan Aushadhi Kendras — Press Information Bureau (06 Feb 2026) — https://www.pib.gov.in/PressReleasePage.aspx?PRID=2224375 — (tier: 1)
• [S2] PMBJP — 16,912 JAKs as on 30.6.2025; 25,000 target by March 2027 (incentives, savings) — https://www.pib.gov.in/PressReleasePage.aspx?PRID=2149782 — (tier: 1)
• [S3] PM inaugurates 10,000th Jan Aushadhi Kendra at AIIMS Deoghar — PIB — https://www.pib.gov.in/PressReleasePage.aspx?PRID=1981190 — (tier: 1)